News for Relief Therapeutics Holding AG (0QKQ.L)

Relief Therapeutics Holding AG announced it has entered into a new exclusive definitive licensing agreement with Acer Therapeutics Inc. for the development and commercialization of OLPRUVA? for the...

By Mary de Wet Acer Therapeutics Inc. has received approval from the Food and Drug Administration for Olpruva, the first of four drugs the company was investigating. The drug, also known... | December 23, 2022

Relief Therapeutics Holding AG press release (RLFTF): 1HRevenue of CHF 3.24M.Net loss for the period was CHF 26.5M, compared to a net loss of CHF 14.7M for the same period last year.

Relief Therapeutics Holding SA / Key word: Interim Report Relief Reports Half-Year 2022 Results and Provides Corporate Update 15-Sep-2022 / 07:00 CET/CEST Release of an ad hoc announcement... | September 15, 2022

Relief Therapeutics Holding SA / Key word: Conference Relief Therapeutics to Participate in the 22nd Annual Biotech in Europe Forum 12.09.2022 / 07:05 CET/CEST Relief... | September 12, 2022

Read Relief Therapeutics Holding AG (OTCMKTS:RLFTF) Short Interest Up 27.8% in May at ETF Daily News

Read Short Interest in Relief Therapeutics Holding AG (OTCMKTS:RLFTF) Grows By 86.2% at ETF Daily News

Read Short Interest in Relief Therapeutics Holding AG (OTCMKTS:RLFTF) Expands By 43.7% at ETF Daily News

Read Short Interest in Relief Therapeutics Holding AG (OTCMKTS:RLFTF) Declines By 48.5% at ETF Daily News

Acer Therapeutics Reports Q4 and Full Year 2021 Financial Results and Provides Corporate Update NEWTON, MA - March 2, 2022 - Acer Therapeutics Inc. , a pharmaceutical company... | March 2, 2022